Clinical Trial Detail

NCT ID NCT00904345
Title Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

laryngeal squamous cell carcinoma

head and neck squamous cell carcinoma

oropharynx cancer

oral squamous cell carcinoma

hypopharynx cancer

Therapies

Cetuximab

Age Groups: senior

No variant requirements are available.